Safety Study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody in Lupus Nephritis
| Status: | Terminated |
|---|---|
| Conditions: | Lupus, Nephrology |
| Therapuetic Areas: | Immunology / Infectious Diseases, Nephrology / Urology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 10/25/2017 |
| Start Date: | November 2011 |
| End Date: | December 2012 |
A Study to Assess the Safety and Tolerability of Anti-MIF Antibody in Subjects With Lupus Nephritis
The purpose of this study is to determine the safety and tolerability of Anti-MIF Antibody in
subjects with lupus nephritis.
subjects with lupus nephritis.
Inclusion Criteria:
- Signed and dated written informed consent obtained from the subject
- Males and females of age 18 years and older at the time of screening
- Established diagnosis of systemic lupus erythematosus (SLE) according to the American
College of Rheumatology classification criteria
- Documented renal biopsy evidence of proliferative glomerulonephritis prior to
screening
- Urine protein-to-creatinine ratio > 0.5 (mg/mg)
Exclusion Criteria:
- Any significant health problem other than lupus or lupus nephritis
We found this trial at
12
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials